Inventor · disambiguated record
Wolfgang Teschner
Also filed as: TESCHNER WOLFGANG
32 granted patents·9 pending applications·310 citations·filing 1994–2023
97Inventor score
Files withBAXALTA INC12BAXTER INT8TAKEDA PHARMACEUTICALS CO7TESCHNER WOLFGANG5BRUCKSCHWAIGER LEOPOLD2
Top patents by PatentIndex Score
41 records- 0195US5608038AHighly concentrated immunoglobulin preparation and method for its productionIMMUNO AG·Filed 1994·Granted Mar 4, 1997·134 cites·19 claims
- 0293US8304524B2Manufacture of factor H (FH) and FH-derivatives from plasmaBAIRSTOW SHAWN F·Filed 2010·Granted Nov 6, 2012·35 cites·17 claims
- 0392US11136350B2Method to produce an immunoglobulin preparation with improved yieldTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 5, 2021·9 cites·23 claims
- 0491US9084743B2Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereofTESCHNER WOLFGANG·Filed 2010·Granted Jul 21, 2015·32 cites·29 claims
- 0590US10738107B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggsBAXALTA INC·Filed 2016·Granted Aug 11, 2020·4 cites·11 claims
- 0690US8546548B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useTESCHNER WOLFGANG·Filed 2010·Granted Oct 1, 2013·17 cites·16 claims
- 0789US9708391B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2016·Granted Jul 18, 2017·3 cites·20 claims
- 0889US8772462B2Removal of serine proteases by treatment with finely divided silicon dioxideTESCHNER WOLFGANG·Filed 2011·Granted Jul 8, 2014·5 cites·18 claims
- 0988US10125189B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useBAXALTA INC·Filed 2015·Granted Nov 13, 2018·7 cites·18 claims
- 1088US9468675B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2014·Granted Oct 18, 2016·4 cites·20 claims
- 1188US8921520B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXTER INT·Filed 2012·Granted Dec 30, 2014·3 cites·21 claims
- 1287US8993734B2Method to produce an immunoglobulin preparation with improved yieldBRUCKSCHWAIGER LEOPOLD·Filed 2010·Granted Mar 31, 2015·14 cites·47 claims
- 1387US2024117009A1Removal of serine proteases by treatment with finely divided silicon dioxideTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1486US9175068B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useBAXTER INT·Filed 2013·Granted Nov 3, 2015·8 cites·24 claims
- 1585US8940877B2Method to produce an immunoglobulin preparation with improved yieldBAXTER INT·Filed 2012·Granted Jan 27, 2015·7 cites·27 claims
- 1685US8709492B2Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metalsTESCHNER WOLFGANG·Filed 2005·Granted Apr 29, 2014·9 cites·32 claims
- 1782US8889838B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXTER INT·Filed 2013·Granted Nov 18, 2014·3 cites·21 claims
- 1880US9556261B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGsBAXALTA INC·Filed 2014·Granted Jan 31, 2017·3 cites·28 claims
- 1979US8796430B2Method to produce an immunoglobulin preparation with improved yieldBRUCKSCHWAIGER LEOPOLD·Filed 2011·Granted Aug 5, 2014·4 cites·109 claims
- 2077US9855331B2Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pHBAXALTA INC·Filed 2014·Granted Jan 2, 2018·1 cites·38 claims
- 2177US8795658B2Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pHBUTTERWECK HARALD ARNO·Filed 2011·Granted Aug 5, 2014·3 cites·34 claims
- 2277US2022153823A1Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2376US11891431B2Removal of serine proteases by treatment with finely divided silicon dioxideTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Feb 6, 2024·0 cites·19 claims
- 2473US12365723B2Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGSTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 22, 2025·0 cites·20 claims
- 2573US10875906B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2019·Granted Dec 29, 2020·0 cites·18 claims
- 2673US9782477B2Fraction I-IV-1 precipitation of immunoglobins from plasmaBAXALTA INC·Filed 2013·Granted Oct 10, 2017·3 cites·61 claims
- 2772US9896501B2Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGsBAXALTA INC·Filed 2014·Granted Feb 20, 2018·1 cites·33 claims
- 2871US8822656B2Manufacture of factor H (FH) and FH-derivatives from plasmaBAXTER INT·Filed 2013·Granted Sep 2, 2014·1 cites·22 claims
- 2968US11242380B2Method to produce a highly concentrated immunoglobulin preparation for subcutaneous useTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 8, 2022·0 cites·11 claims
- 3067US10208106B2Removal of serine proteases by treatment with finely divided silicon dioxideBAXALTA INC·Filed 2017·Granted Feb 19, 2019·0 cites·18 claims
- 3162US2015133644A1Method to produce an immunoglobulin preparation with improved yieldBAXTER INT·Filed 2014·Application pending·0 cites
- 3261US2018250401A1Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral phBAXALTA INC·Filed 2017·Application pending·0 cites
- 3357US9109044B2Manufacture of factor H (FH) and FH-derivatives from plasmaBAXTER INT·Filed 2012·Granted Aug 18, 2015·0 cites·17 claims
- 3457US2014234292A1Process for Producing a Plasma Protein-Containing MedicamentBAXTER INNOVATIONS GMBH·Filed 2014·Application pending·0 cites
- 3550US2013224184A1Method to produce an immunoglobulin preparation with improved yieldBAXTER INT·Filed 2013·Application pending·0 cites
- 3649US2003069174A1Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparationFiled 2002·Application pending·0 cites
- 3748US2023142480A1A method to produce an immunoglobulin preparation from c-1 inhibitor depleted plasmaTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 3841US10183976B2Method for producing factor H from a plasma precipitation fractionBAXALTA INC·Filed 2014·Granted Jan 22, 2019·0 cites·19 claims
- 3940US9783792B2Purification of butyrylcholinesterase using membrane adsorptionZAYDENBERG ALEXANDER·Filed 2009·Granted Oct 10, 2017·0 cites·13 claims
- 4038US9403899B2Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin compositionTESCHNER WOLFGANG·Filed 2012·Granted Aug 2, 2016·0 cites·28 claims
- 4127US2002034809A1Process for producing a plasma protein-containing medicamentFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wolfgang Teschner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →